Brief: Herantis Pharma H1 Loss For Period Widens To EUR 7.9 Mln

Herantis Pharma Oyj

26/08/2021 07:35

Aug 26 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * RESULTS FOR THE FIRST HALF YEAR JANUARY 1 - JUNE 30, 2021
    * DURING 2021 WE WILL CONTINUE EXECUTING ROADMAP AS WE AIM
TO
COMPLETE FORMULATION ACTIVITIES FOR NEW CDNF ADMINISTRATIONS
ROUTES
    * H1 LOSS FOR PERIOD EUR 7.9 MILLION  VERSUS LOSS EUR 4.5
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr7Fwd2T 
Further company coverage:  HRTIS.HE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))